Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
KMUP 1 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01356
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
KMUP 1 induces the drug-metabolizing activity of DME NOS1 |
[1] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Lead chloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01506
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Health and Environmental Toxicant |
DME Modulation |
Lead chloride inhibits the drug-metabolizing activity of DME NOS1 |
[2] |
Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Diethylhexyl phthalate inhibits the expression of DME NOS1 |
[3] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Apocarotenal |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01523
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Apocarotenal up-regulates the expression of DME NOS1 |
[4] |
Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Plant extracts |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01574
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Plant Extract |
DME Modulation |
Plant extracts inhibits the drug-metabolizing activity of DME NOS1 |
[5] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
Beta carotene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00401
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Beta carotene up-regulates the expression of DME NOS1 |
[4] |
Capsaicin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00178
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Capsaicin induces the drug-metabolizing activity of DME NOS1 |
[6] |
Copper |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00834
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper induces the drug-metabolizing activity of DME NOS1 |
[7] |
Hydrogen peroxide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00388
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Hydrogen peroxide induces the drug-metabolizing activity of DME NOS1 |
[8] |
Selenomethionine Se-75 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00324
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Selenomethionine Se-75 up-regulates the expression of DME NOS1 |
[9] |
Testosterone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00095
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Testosterone induces the drug-metabolizing activity of DME NOS1 |
[10] |
Lycopene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00849
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Lycopene inhibits the drug-metabolizing activity of DME NOS1 |
[11] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Resveratrol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00568
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Resveratrol up-regulates the expression of DME NOS1 |
[12] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A induces the drug-metabolizing activity of DME NOS1 |
[13] |
MS-275 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MS-275 up-regulates the expression of DME NOS1 |
[14] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Egtazic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01286
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
Egtazic acid inhibits the drug-metabolizing activity of DME NOS1 |
[15] |
Oxidopamine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01418
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
Oxidopamine up-regulates the expression of DME NOS1 and leads to increasing the drug-metabolizing activity of this enzyme |
[16] |
|
|
|
|
|
|